Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. Companies
  3. lithuania
  4. solid tumor
Show results for
Products
Services
Software
Applications

Companies


Refine by
Locations
Back to All Locations

  • Europe
  • Lithuania
Business Types

  • Manufacturer
  • Technology
  • Service provider
  • Software vendor
Industries served

  • Medical / Health Care
  • Monitoring and Testing
  • Chemical & Pharmaceuticals
  • Environmental
Employees

  • Over 1000
  • 101-1000

Solid Tumor Suppliers Serving Lithuania

66 companies found
In LithuaniaServing LithuaniaNear Lithuania

MorphoSys AG

MorphoSys AG

based inPlanegg, GERMANY
MorphoSys is a commercial-stage biopharmaceutical company dedicated to the discovery, development, and delivery of innovative cancer medicines. At MorphoSys, our ambition is to redefine how cancer is treated. As a commercial-stage biopharmaceutical ...
Tulmimetostat - Model CPI-0209 - Second-Generation EZH2 Inhibitor

Tulmimetostat - Model CPI-0209 - Second-Generation EZH2 Inhibitor

Tulmimetostat is a second-generation EZH2 inhibitor that has been designed to achieve comprehensive target coverage through extended on-target residence time. EZH2 acts as an epigenetic writer and normally places one or more methyl groups on a ...
CONTACT SUPPLIER

Lucence Health Inc.

Lucence Health Inc.

based inPalo Alto, CALIFORNIA (USA)
Lucence is a precision oncology company committed to bringing clarity to cancer care. Lucence makes ultrasensitive non-invasive liquid biopsy tests to provide doctors and their patients life-changing information to enable earlier detection and ...
Lucence Tissue500 - Comprehensive Genomic Profiling Test

Lucence Tissue500 - Comprehensive Genomic Profiling Test

Tissue500™ is a comprehensive genomic profiling test that detects clinically relevant mutations in 572 genes to identify a patient’s unique cancer ...
CONTACT SUPPLIER

Stemline Therapeutics, Inc.

Stemline Therapeutics, Inc.

based inNew York, NEW YORK (USA)
Stemline Therapeutics is a commercial-stage biopharmaceutical company focused on the development and commercialization of novel oncology therapeutics. The goal of our dedicated team of scientists, specialists, researchers, and developers is to build ...
Stemline - Model XPO1 - Regulate Nuclear Export

Stemline - Model XPO1 - Regulate Nuclear Export

XPO1 has been shown to regulate nuclear export of many of the major tumor suppressor proteins and oncogenic cell growth regulators. Overexpression of XPO1 has been reported in many cancer types and is associated with aggressive ...
CONTACT SUPPLIER

Thermo Fisher Scientific, LIMS & Laboratory Software

Thermo Fisher Scientific, LIMS & Laboratory Software

based inPhiladelphia, PENNSYLVANIA (USA)
With extensive experience optimising processes for analytical, production and R&D laboratories across multiple industries and regulatory environments, we provide consistent, quality informatics solutions. We operate on a truly global basis, serving ...
Oncomine Clinical Research Grant Program

Oncomine Clinical Research Grant Program

The Oncomine Clinical Research Grant Program supports investigator-initiated studies (IIS) and education projects, on molecular testing in oncology and reproductive health, with the goal to increase high quality molecular profiling for patients and ...
CONTACT SUPPLIER

OSE Immunotherapeutics

OSE Immunotherapeutics

based inNantes, FRANCE
OSE Immunotherapeutics is an integrated biotechnology company focused on developing and partnering therapies to control the immune system for immuno-oncology and autoimmune diseases. Based in Nantes (Head Office) and Paris, OSE Immunotherapeutics ...
CONTACT SUPPLIER

Affimed GmbH

Affimed GmbH

based inHeidelberg, GERMANY
We are a team of passionate, experienced individuals who work every day to improve the lives of patients. Led by an expert team of biotechnology and pharmaceutical professionals, we are united by one goal—to stop cancer from ever derailing patients’ ...
Affimed - Model AFM13 - Innate Cell Engager Molecule

Affimed - Model AFM13 - Innate Cell Engager Molecule

Lighting the way with clinical results: we are creating success with monotherapies and combination therapies. AFM13, a first-in-class ICE (innate cell engager) molecule targeting patients with CD30-positive lymphomas,4 showed antitumor responses in ...
CONTACT SUPPLIER

Sequoia Vaccines, Inc.

Sequoia Vaccines, Inc.

based inSaint Louis, MISSOURI (USA)
Sequoia Vaccines is a clinical stage pharmaceutical company discovering and developing new vaccines preventing bacterial infections and medicines treating cancers and bacterial infections. Sequoia’s lead clinical candidate is a vaccine for the ...
Sequoia - Model SQ1274 - Anticancer Compound

Sequoia - Model SQ1274 - Anticancer Compound

Sequoia is developing an anticancer compound (SQ1274) for use against solid tumors including ovarian and lung ...
CONTACT SUPPLIER

IMB Dx, Inc.

IMB Dx, Inc.

based inSeoul, SOUTH KOREA
We detect and analyze genomic profile of tumor DNA with a single draw of blood. With this comprehensive profile, we provide personalized and optimized analysis information that can be utilized in therapy selection and monitoring. Ultimately, we ...
AlphaLiquid - Model Detect - Tumor-Informed, Hybrid-Capture NGS-Based Liquid Biopsy Test

AlphaLiquid - Model Detect - Tumor-Informed, Hybrid-Capture NGS-Based Liquid Biopsy Test

AlphaLiquid® Detect is an industry-first tumor-informed, hybrid-capture NGS-based liquid biopsy test designed for MRD detection and recurrence monitoring in stage I-III solid tumor patients. The ...
CONTACT SUPPLIER

Genmab A/S

Genmab A/S

based inCopenhagen V, DENMARK
Founded in 1999 in Copenhagen, Denmark, we are a dual-listed, international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer. We are led by an experienced ...
Genmab DuoBody - Model CD3xB7H4 (GEN1047) - Proprietary Bispecific Antibody

Genmab DuoBody - Model CD3xB7H4 (GEN1047) - Proprietary Bispecific Antibody

DuoBody-CD3xB7H4 (GEN1047) is a proprietary bispecific antibody created using Genmab’s DuoBody® technology. B7H4 is an immune checkpoint protein expressed on malignant cells in various solid cancers including breast, ...
CONTACT SUPPLIER

Antengene Corporation Limited

Antengene Corporation Limited

based inChangning District, CHINA
Antengene Corporation Limited (“Antengene”, SEHK: 6996.HK) is a leading commercial-stage R&D-driven global biopharmaceutical company focused on the discovery, development, manufacturing and commercialization of innovative ...
CONTACT SUPPLIER

Celularity Inc.

Celularity Inc.

based inFlorham Park, NEW JERSEY (USA)
Celularity, headquartered in Florham Park, N.J., is a clinical stage biotechnology company leading the next evolution in cellular medicine by delivering off-the-shelf allogeneic placenta-derived cellular therapies at unparalleled scale, quality and ...
Celularity - Model CAR-T - Chimeric Antigen Receptor T Cells

Celularity - Model CAR-T - Chimeric Antigen Receptor T Cells

Chimeric Antigen Receptor T cells (CAR-T) are genetically engineered T cells that are modified to express an artificial T cell receptor on their surface that binds and targets cancer proteins in an HLA-independent ...
CONTACT SUPPLIER

RedHill Biopharma Ltd.

RedHill Biopharma Ltd.

based inTel-Aviv, ISRAEL
RedHill Biopharma (NASDAQ: RDHL) is driven to develop extraordinary medicines for people to live extraordinary lives. RedHill applies innovation, focus and a collective mindset of delivering on our promises, to build a company at the forefront of ...
CONTACT SUPPLIER

MitoImmune Therapeutics Inc.

MitoImmune Therapeutics Inc.

based inGangnam-gu, SOUTH KOREA
MitoImmune Therapeutics Inc. is a drug discovery and development biotech company that harnesses the power of mitochondria and its proprietary technology targeting mitochondria as the source for developing new potential breakthrough therapeutics. Our ...
CONTACT SUPPLIER

Senti Biosciences

Senti Biosciences

based inSouth San Francisco, CALIFORNIA (USA)
Senti Bio was founded to create a new generation of smarter medicines that outmaneuver complex diseases using novel and unprecedented approaches. Senti Bio designs and optimizes gene circuits, which are created from novel and proprietary ...
Model SENTI-301 - Multi-Armed Allogeneic CAR-NK Cell Therapy for HCC

Model SENTI-301 - Multi-Armed Allogeneic CAR-NK Cell Therapy for HCC

The product profile of SENTI-301 has the potential to promote expansion and persistence of NK cells, and activate and recruit the body’s own immune cells into the solid tumor microenvironment for ...
CONTACT SUPPLIER

Immatics N.V.

Immatics N.V.

based inTuebingen, GERMANY
Immatics combines the discovery of true targets for cancer immunotherapies with the development of the right T cell receptors with the goal of enabling a robust and specific T cell response against these targets. This deep know-how is the foundation ...
ACTengine - Next-generation Enhancement Strategies

ACTengine - Next-generation Enhancement Strategies

Immatics’ latest proprietary ACTengine® manufacturing processes are designed to generate cell product candidates within a short manufacturing window and deliver highly proliferative T cells, with the capability to infiltrate the ...
CONTACT SUPPLIER

Celluris

Celluris

based inSão Paulo, BRAZIL
Celluris is the first company in Latin America to develop personalized treatment for cancer patients through CAR-T immunotherapy. This technique is based on the modification of the patient’s own cells into recognizing the tumor as a target, fighting ...
Model CAR-T - Chimeric T Cell Antigen Receptor Therapy

Model CAR-T - Chimeric T Cell Antigen Receptor Therapy

The chimeric T cell antigen receptor therapy, also known as CAR-T, is an immunotherapy that is innovating the treatment of hematological and solid tumors. This new technology is considered less aggressive than ...
CONTACT SUPPLIER

Shanghai Henlius Biotech, Inc

Shanghai Henlius Biotech, Inc

based inShanghai, CHINA
Henlius (2696.HK) is a global biopharmaceutical company with the vision to offer high-quality, affordable and innovative biologic medicines for patients worldwide with a focus on oncology, autoimmune diseases and ophthalmic diseases. Up to date, 5 ...
Henlius - Model HLX07 - Recombinant Anti-Epidermal Growth Factor Receptor (EGFR) Humanised Monoclonal Antibody Injection

Henlius - Model HLX07 - Recombinant Anti-Epidermal Growth Factor Receptor (EGFR) Humanised Monoclonal Antibody Injection

HLX07, recombinant anti-epidermal growth factor receptor (EGFR) humanised monoclonal antibody injection independently researched and developed as biobetter. It was granted IND approvals to be evaluated in clinical trials in China and the United ...
CONTACT SUPPLIER

Pyrexar

Pyrexar

based inSalt Lake City, UTAH (USA)
PYREXAR Medical is the pioneer and worldwide market leader in the development and manufacture of innovative and highly effective hyperthermia treatment systems with established global distribution. PYREXAR Hyperthermia treatments increase the ...
Pyrexar - Model BSD-2000 3D - Deep Regional Hyperthermia System

Pyrexar - Model BSD-2000 3D - Deep Regional Hyperthermia System

Deep Regional system using an annular phased array configuration to shape and focus thermal energy on targeted treatment using Sigma Eye Wave ...
CONTACT SUPPLIER

Creative Biolabs

Creative Biolabs

based inShirley, NEW YORK (USA)
After decades of research and accumulation, Creative Biolabs has become a leader in the discovery and manufacturing of recombinant antibodies (rAbs), providing the most reliable and qualified services to customers in academia and industry around the ...
Creative Biolabs - Model TAB-013ML (CAT#: TAB-013ML) - Anti-Human ENG Recombinant Antibody

Creative Biolabs - Model TAB-013ML (CAT#: TAB-013ML) - Anti-Human ENG Recombinant Antibody

It is a human monoclonal antibody that can be potentially used in the treatment of Hepatocellular Carcinoma, Gestational Trophoblastic Neoplasia, Choriocarcinoma, Placental Site Trophoblastic Tumor, Epithelioid Trophoblastic ...
CONTACT SUPPLIER

SystImmune Inc.

SystImmune Inc.

based inRedmond, WASHINGTON (USA)
SystImmune Inc. is a biopharmaceutical company focused on the treatment of cancer through developing novel therapeutic bi-specific, and multi-specific antibodies, as well as antibody-drug conjugates (ADCs). Our objective is to create biologics that ...
SystImmune - Model GNC-035 - Guidance and Navigation Control (GNC) Molecules

SystImmune - Model GNC-035 - Guidance and Navigation Control (GNC) Molecules

Guidance and Navigation Control (GNC) molecules are multi-specific cell engager proteins. GNC in the oncology therapeutics class bind to cancer cells and to immune cells and stimulate the immune cell cancer killing activity. By design, each GNC ...
CONTACT SUPPLIER
  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical Equipment & Supplies
  • Medical Software
  • Medical Training Courses
  • Medical Industry Services
  • Medical Product Applications

Latest

  • Medical Industry News
  • Medical Industry Events

Publications

  • Medical Industry Articles & Case Studies
  • Medical Industry Books and Publications
  • Medical Industry Journals and Magazines
  • Medical Industry Downloads
  • Medical Industry Videos

Companies

  • Medical Industry Suppliers & Manufacturers

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT